First Patient Treated in Ph I/II of Lu177-PentixaTher for Leukemia
21 Nov 2024 //
GLOBENEWSWIRE
Pentixapharm scores $22M in IPO to advance radiopharma trials
03 Oct 2024 //
FIERCE BIOTECH
Pentixapharm Acquires Target Discovery Business of Glycotope
03 Jul 2024 //
GLOBENEWSWIRE
Pentixapharm Receives FDA Feedback for Phase III Trial with PentixaFor
25 Jun 2024 //
GLOBENEWSWIRE